Hosted on MSN
MapLight’s ML-004 autism extension study: What ongoing safety data mean for investors
MapLight Therapeutics, Inc. (MPLT) announced an update on their ongoing clinical study. Study Overview MapLight Therapeutics is running an extension study called “An Open-label Extension Study to ...
Morning Overview on MSN
Lab-grown brain organoids show distinct signals across autism types
Researchers have recorded distinct electrical activity patterns from lab-grown brain organoids derived from people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results